Company intelligence / Profile preview

Stability Biologics

Nashville, Tennessee, United Statesstabilitybio.com ↗

Ownership: Private
Employees: ~35
Development stage: Commercial

Overview

Stability Biologics offers a full line of advanced human allograft and biologic products for use in spine, orthopedics, and wound care. Their AmnioCore amnion patch received a unique CMS Q-code in July 2020. The company operates an AATB-accredited tissue bank and has experienced significant sales growth since the launch of its proprietary products. No clinical trial data are published; their products are marketed as medical devices/biologic implants.

Therapeutic areas: OtherDermatologyNeurology
Modalities: AllograftBiologicMedical deviceRegenerative medicine product
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Physio

Commercial

Indications: Bone grafting

Partnerships

None publicly disclosed; distributes to hospitals/surgeons nationally.

Beyond the preview

Go deeper on Stability Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stability Biologics.